Showing results (1-10 of 134) with videos related to
Sort By:
Pageof 14
Journal of Patient-Reported Outcomes|July 17, 2023
Evaluating meaningful changes in physical functioning and cognitive declines in metachromatic leukodystrophy: a caregiver interview studySusan Martin, Nimanee Harris, Dorothy RomanusDermatology and Therapy|March 22, 2021
Development of the Alopecia Areata Patient Priority Outcomes Instrument: A Qualitative StudyRandall Winnette, Susan Martin, Nimanee Harris, et al.Advances in Therapy|June 12, 2019
Development of a Patient-Reported Outcome Measure for Chronic HypoparathyroidismSusan Martin, Kristina Chen, Nimanee Harris, et al.Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Qualitative Analysis of Pain in Patients With Locally Advanced or Metastatic Urothelial CarcinomaSusan Martin, Sonali N Shah, Zsolt Hepp, et al.Laryngoscope Investigative Otolaryngology|January 2, 2019
Nosebleeds in hereditary hemorrhagic telangiectasia: Development of a patient-completed daily eDiaryMarci Clark, Pamela Berry, Susan Martin, et al.Patient Related Outcome Measures|February 19, 2019
Psychometric evaluation of the hypoparathyroidism symptom diaryTheresa Coles, Kristina Chen, Lauren Nelson, et al.The British Journal of Dermatology|October 4, 2024
Content evaluation of pruritus, skin pain and sleep disturbance patient-reported outcome measures for adolescents and adults with moderate-to-severe atopic dermatitis: qualitative interviewsAndrew Blauvelt, Jennifer Reckleff, Yang Zhao, et al.Journal of Comparative Effectiveness Research|May 23, 2023
Network meta-analysis for indirect comparison of lanadelumab and berotralstat for the treatment of hereditary angioedemaMaureen Watt, Mia Malmenäs, Dorothy Romanus, et al.Journal of Patient-Reported Outcomes|June 3, 2022
Patient experiences with patient-reported outcome measures in metastatic breast cancer trials: qualitative interviewsCarla Romano, Nimanee Harris, Ari Gnanasakthy, et al.Contemporary Clinical Trials|July 28, 2022
A review of patient-reported outcome assessments in registration trials of FDA-approved new oncology drugs (2014-2018)Ari Gnanasakthy, Jon Russo, Kajan Gnanasakthy, et al.Pageof 14